A new agent, blue and radioactive, for sentinel node detection

被引:8
作者
El-Tamer, M
Saouaf, R
Wang, T
Fawwaz, R
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA
关键词
sentinel node; phthalocyanine; radiotracer; isosulfanblue;
D O I
10.1245/ASO.2003.03.087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although with some disadvantages, combining radiotracer and isosulfan blue facilitates the detection of sentinel lymph nodes. This study was designed to evaluate the use of Tc-99m-labeled phthalocyanine tetrasulfonate (Tc-99m-PCTS) as a single agent for simultaneous blue staining and radiotracer localization of the sentinel lymph node. Methods: Twelve rabbits were injected into the dermis and subcutaneously in the distal hind limb with 1 mL of blue Tc-99m-PCTS (.5 mCi). The popliteal and inguinal fossae were explored between 15 minutes and 24 hours after injection for blue and/or radioactive tissue. Popliteal and inguinal fossae and other lymph nodes and organs were harvested for determination of the concentration of radioactivity and for histology. Results: Within minutes of Tc-99m-PCTS injection, the lymphatic channels were easily identified by the blue color. At 10 minutes, the radioactive count over the popliteal fossa was significantly higher than over other areas. At exploration, a blue and radioactive popliteal node was identified in all animals; inguinal nodes were neither blue nor radioactive. At death, the radioactivity in the popliteal node was 1000 times higher than in other nodes or organs. Although fainter, the blue color in the popliteal node was still visible at 6 weeks. Histological sections of popliteal node identified the dye in the cytoplasmic compartment of the cells. Conclusions: Technetium-99m PCTS is a single agent that identifies sentinel lymph nodes by color and radioactivity and is retained for an extended period of time without migrating to other tissues.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 47 条
  • [1] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
    Albertini, JJ
    Lyman, GH
    Cox, C
    Yeatman, T
    Balducci, L
    Ku, NN
    Shivers, S
    Berman, C
    Wells, K
    Rapaport, D
    Shons, A
    Horton, J
    Greenberg, H
    Nicosia, S
    Clark, R
    Cantor, A
    Reintgen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1818 - 1822
  • [2] GAMMA-PROBE-GUIDED LYMPH-NODE LOCALIZATION IN MALIGNANT-MELANOMA
    ALEX, JC
    WEAVER, DL
    FAIRBANK, JT
    RANKIN, BS
    KRAG, DN
    [J]. SURGICAL ONCOLOGY-OXFORD, 1993, 2 (05): : 303 - 308
  • [3] Accuracy of sentinel lymph node in papillary thyroid carcinoma
    Arch-Ferrer, J
    Valázquez, D
    Fajardo, R
    Gamboa-Domínguez, A
    Herrera, MF
    [J]. SURGERY, 2001, 130 (06) : 907 - 913
  • [4] Beitsch P D, 2001, Breast J, V7, P219, DOI 10.1046/j.1524-4741.2001.20120.x
  • [5] Phase I study on sentinel lymph node mapping in colon cancer:: A preliminary report
    Bendavid, Y
    Latulippe, JF
    Younan, RJ
    Leclerc, YE
    Dube, S
    Heyen, F
    Morin, M
    Girard, R
    Bastien, E
    Ferreira, J
    Cerino, M
    Dubé, P
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (02) : 81 - 84
  • [6] Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer
    Bergkvist, L
    Frisell, J
    Liljegren, G
    Celebioglu, F
    Damm, S
    Thörn, M
    [J]. BRITISH JOURNAL OF SURGERY, 2001, 88 (12) : 1644 - 1648
  • [7] BIGELOW NM, 1955, CHEM SYNTHETIC DYES, P577
  • [8] Current surgical management of breast cancer
    Cody, HS
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2002, 14 (01) : 45 - 52
  • [9] Cox C E, 2001, Ann Surg Oncol, V8, p67S
  • [10] Cox CE, 1998, ONCOLOGY-NY, V12, P1283